Drug Type Degradable Molecular Glue |
Synonyms BI 3802, BI3802 |
Target |
Action degraders |
Mechanism BCL6 degraders(B-cell lymphoma 6 protein degraders) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H29ClN6O3 |
InChIKeyGXTJETQFYHZHNB-GASCZTMLSA-N |
CAS Registry2166387-65-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | United States | 01 Dec 2020 | |
| Lymphoma | Discovery | United States | 19 Sep 2017 | |
| Lymphoma | Discovery | United States | 19 Sep 2017 |





